TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35763660

Group type: EXPERIMENTAL
Intervention: EUS-FNA (Echotip 22Gauge FNA needle)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: EUS-FNB (22Gauge acquire FNB needle)
Number of subjects: 100

Group type: COMPARATOR
Intervention: EUS-FNA
Number of subjects: 100

Group type: COMPARATOR
Intervention: EUS-FNB
Number of subjects: 100
Study: 32757075

Group type: EXPERIMENTAL
Intervention: 0.12% CHX + 1.5% H2O2 mouthrinse
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.12% CHX
Number of subjects: 60
Study: 35623631

Group type: EXPERIMENTAL
Intervention: Peer‐facilitated trauma‐specific intervention (Exploring Trauma: A 6‐Session Brief Intervention for Men)
Number of subjects: 221

Group type: COMPARATOR
Intervention: Waitlisted control group
Number of subjects: 221
Study: 34444703

Group type: EXPERIMENTAL
Intervention: β-alanine (20 g per day for 7 days)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 32418818

Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 2178
Study: 35764009

Group type: EXPERIMENTAL
Intervention: SFA
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: FO
Number of subjects: 8

Group type: COMPARATOR
Intervention: Con
Number of subjects: 8
Study: 34172032

Group type: EXPERIMENTAL
Intervention: Virtual reality distraction (watching a cartoon video using virtual reality goggles)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (watching a cartoon video on a screen)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (regardless of distraction technique)
Number of subjects: 50
Study: 33355605

Group type: EXPERIMENTAL
Intervention: Consistently short or consistently long femur lengths (FL)
Number of subjects: 498

Group type: EXPERIMENTAL
Intervention: Faster growth trajectories of head circumference (HC), femur length (FL), or estimated fetal weight (EFW)
Number of subjects: 498
Study: 36323344

Group type: EXPERIMENTAL
Intervention: Greenlight intervention
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Greenlight Plus intervention
Number of subjects: 900
Study: 32516282

Group type: EXPERIMENTAL
Intervention: Baloxavir
Number of subjects: 173

Group type: COMPARATOR
Intervention: Oseltamivir
Number of subjects: 173
Study: 35103836

Group type: EXPERIMENTAL
Intervention: 600 mg of ibuprofen, administered intravenously twice daily.
Number of subjects: 109

Group type: COMPARATOR
Intervention: 75 mg diclofenac plus 30 mg orphenadrine, administered intravenously twice daily.
Number of subjects: 109
Study: 35716692

Group type: EXPERIMENTAL
Intervention: eptinezumab 100 mg
Number of subjects: 891

Group type: EXPERIMENTAL
Intervention: eptinezumab 300 mg
Number of subjects: 891

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 891
Study: 32545689

Group type: EXPERIMENTAL
Intervention: CpG‐A (100 g/kg)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: CpG‐A and Placebo
Number of subjects: 42
Study: 35546299

Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT) with 915 nm diode laser (1.5 W, duty cycle of 60%, energy density of 72 J/cm2)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham laser (no irradiation)
Number of subjects: 32
Study: 33084019

Group type: EXPERIMENTAL
Intervention: Oral health educational and behavioral intervention program (two 1-hour sessions)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 66
Study: 34088322

Group type: EXPERIMENTAL
Intervention: L-tyrosine-adsorbed allergen extracts
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 0
Study: 32297283

Group type: EXPERIMENTAL
Intervention: OPTIMA-PA questionnaire
Number of subjects: 154

Group type: COMPARATOR
Intervention: Standard group (usual clinical practice)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: GP patient-centredness
Number of subjects: 154
Study: 32140973

Group type: EXPERIMENTAL
Intervention: 16-week exercise intervention
Number of subjects: 240
Study: 32996802

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 101
Study: 35696128

Group type: EXPERIMENTAL
Intervention: Red blood cell transfusions from female donors
Number of subjects: 368778

Group type: EXPERIMENTAL
Intervention: Red blood cell transfusions from parous female donors
Number of subjects: 368778

Group type: COMPARATOR
Intervention: Red blood cell transfusions from male donors
Number of subjects: 368778
Study: 34319221

Group type: EXPERIMENTAL
Intervention: Machine learning models using metadata and text features for suicidality detection.
Number of subjects: 20000

Group type: EXPERIMENTAL
Intervention: Metadata features including posting type (reply vs. original), time of day, and day of the week.
Number of subjects: 20000
Study: 32718986

Group type: EXPERIMENTAL
Intervention: adagloxad simolenin (AS/OBI-821) with adjuvant OBI-821
Number of subjects: 349

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: adagloxad simolenin (AS/OBI-821) with anti-Globo H IgG titer ≥1:160
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: adagloxad simolenin (AS/OBI-821) with anti-Globo H IgG titer <1:160
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: AS/OBI-821
Number of subjects: 349
Study: 36109599

Group type: EXPERIMENTAL
Intervention: Isometric exercise training (IET)
Number of subjects: 24
Study: 34604396

Group type: EXPERIMENTAL
Intervention: Abdominal massage with extra-virgin olive oil for five consecutive days (15 minutes each day)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Abdominal massage with water for five consecutive days (15 minutes each day)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (no specific intervention)
Number of subjects: 54
Study: 36274285

Group type: EXPERIMENTAL
Intervention: Posterior tibial nerve stimulation (PTNS)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (pelvic floor muscle training)
Number of subjects: 40
Study: 35316372

Group type: EXPERIMENTAL
Intervention: 6-week supervised concurrent chair-based exercise program (stretching, strength, balance exercises, aerobic dance; 5 days/week, 30-40 min/day, 2 workouts/day lasted 15-20 min)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 50
Study: 32280208

Group type: EXPERIMENTAL
Intervention: Chinese herbal medicines (CHMs)
Number of subjects: 3360

Group type: COMPARATOR
Intervention: Non-CHMs users
Number of subjects: 3360
Study: 35770308

Group type: EXPERIMENTAL
Intervention: Fractional Er: YAG 2940 nm laser
Number of subjects: 20

Group type: COMPARATOR
Intervention: Q‐Switched Nd: YAG 1064 nm laser
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Patient satisfaction levels after treatment in Area A (Fractional Er: YAG)
Number of subjects: 20
Study: 32632986

Group type: EXPERIMENTAL
Intervention: Sildenafil 50 mg
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 32623977

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure-lowering therapy (target systolic BP, 110-139 mm Hg)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Standard blood pressure-lowering therapy (target systolic BP, 140-179 mm Hg)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Comparison of intensive vs standard BP-lowering therapy
Number of subjects: 1000
Study: 36260615

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (160 mg daily from inclusion to 34 weeks of gestation)
Number of subjects: 1104

Group type: COMPARATOR
Intervention: Placebo (daily from inclusion to 34 weeks of gestation)
Number of subjects: 1104

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin
Number of subjects: 1104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1104
Study: 33791377

Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma (PRP) therapy at the surgical site
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (no PRP therapy)
Number of subjects: 12
Study: 32663149

Group type: EXPERIMENTAL
Intervention: Response rates among older men (aged 65-70)
Number of subjects: 6756

Group type: EXPERIMENTAL
Intervention: Response rates in rural areas
Number of subjects: 6756

Group type: EXPERIMENTAL
Intervention: Response rates in areas with higher tax base
Number of subjects: 6756
Study: 35576245

Group type: EXPERIMENTAL
Intervention: Guided bone regeneration (GBR) with xenograft (DBBM, Bio‐Oss®) and absorbable membrane (Bio‐Gide®)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Cystectomy without any filling material (Control group)
Number of subjects: 67
Study: 34549922

Group type: EXPERIMENTAL
Intervention: Tetric EvoCeram Bulk Fill with a 4-mm layer thickness
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: SDR in combination with Tetric EvoCeram Bulk Fill with a 2-mm layer thickness
Number of subjects: 94

Group type: COMPARATOR
Intervention: Tetric EvoCeram with a 2-mm layer thickness
Number of subjects: 94
Study: 36521773

Group type: EXPERIMENTAL
Intervention: Acupuncture intervention combined with pharmacologic treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pharmacologic treatment only (Control)
Number of subjects: 0
Study: 32168288

Group type: EXPERIMENTAL
Intervention: High-fidelity (HF) simulation-based learning on themes A, B, and C
Number of subjects: 166

Group type: COMPARATOR
Intervention: Standard education on themes D, E, and F
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: High-fidelity (HF) simulation-based learning
Number of subjects: 166

Group type: COMPARATOR
Intervention: Standard education
Number of subjects: 166
Study: 35044992

Group type: EXPERIMENTAL
Intervention: Experimental intervention (pushing a medicine ball attached to the ceiling using their unaffected upper extremity)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control intervention (self‐guided general mobility exercise program)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Experimental intervention
Number of subjects: 6
Study: 35010951

Group type: EXPERIMENTAL
Intervention: High Stress (HS) group
Number of subjects: 61

Group type: COMPARATOR
Intervention: Very High Stress (VHS) group
Number of subjects: 61
Study: 35167700

Group type: EXPERIMENTAL
Intervention: mild Procedure + Conventional Medical Management (CMM)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Conventional Medical Management (CMM) alone
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: mild Procedure + CMM
Number of subjects: 138

Group type: COMPARATOR
Intervention: CMM alone
Number of subjects: 138
Study: 32706181

Group type: EXPERIMENTAL
Intervention: Finnish RCT
Number of subjects: 403

Group type: COMPARATOR
Intervention: Singaporean SCORM Matched 9-year-olds
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: Finnish RCT 11-year-olds
Number of subjects: 403

Group type: COMPARATOR
Intervention: Singaporean SCORM Matched 11-year-olds
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: SCORM 7-year-olds
Number of subjects: 403

Group type: COMPARATOR
Intervention: Singaporean SCORM Matched
Number of subjects: 403
Study: 32482112

Group type: EXPERIMENTAL
Intervention: Alendronate (70 mg/week, n=22)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Recombinant human parathyroid hormone (20 μg/day, n=35)
Number of subjects: 60
Study: 35719024

Group type: EXPERIMENTAL
Intervention: Family Focused Therapy (FFT-CHR)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Enhanced Care (EC)
Number of subjects: 129
Study: 33648576

Group type: EXPERIMENTAL
Intervention: Blended cognitive behaviour therapy (PowerMe intervention) targeting fatigue, tailored to individual treatment plans, duration of 33 weeks with a baseline period of 5 to 9 weeks before intervention.
Number of subjects: 10
Study: 32700409

Group type: EXPERIMENTAL
Intervention: Pharmacy care (n = 110)
Number of subjects: 237

Group type: COMPARATOR
Intervention: Usual care (n = 127)
Number of subjects: 237
Study: 33035763

Group type: EXPERIMENTAL
Intervention: Monthly oral health intervention by dental hygienists for 8 months
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 55
Study: 32565477

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) teaching for SSI prevention measures
Number of subjects: 3

Group type: COMPARATOR
Intervention: Conventional education programme
Number of subjects: 3
Study: 35073805

Group type: EXPERIMENTAL
Intervention: Specificity prompts
Number of subjects: 228

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 228
Study: 34423771

Group type: EXPERIMENTAL
Intervention: Theracurmin
Number of subjects: 24

Group type: COMPARATOR
Intervention: Curcumin powder
Number of subjects: 24
Study: 34078975

Group type: EXPERIMENTAL
Intervention: N2O (70%)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Air (70%)
Number of subjects: 140
Study: 32094333

Group type: EXPERIMENTAL
Intervention: Stress induction (socially evaluated cold‐pressor test)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Functional connectivity assessment of the caudate nucleus and posterior putamen
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Functional connectivity assessment of the posterior putamen
Number of subjects: 46
Study: 32247304

Group type: COMPARATOR
Intervention: Omalizumab
Number of subjects: 0
Study: 33589406

Group type: EXPERIMENTAL
Intervention: Shenyankangfu Tablet (SYKFT)
Number of subjects: 735

Group type: COMPARATOR
Intervention: Losartan potassium 50 mg
Number of subjects: 735

Group type: EXPERIMENTAL
Intervention: SYKFT plus losartan potassium 50 mg
Number of subjects: 735

Group type: EXPERIMENTAL
Intervention: SYKFT plus losartan potassium 100 mg
Number of subjects: 735

Group type: EXPERIMENTAL
Intervention: SYKFT
Number of subjects: 735

Group type: COMPARATOR
Intervention: Control group (no SYKFT)
Number of subjects: 735
Study: 32176112

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA) 1g in 100mL saline solution applied for 5 minutes before wound closure
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA)
Number of subjects: 0
Study: 34890045

Group type: EXPERIMENTAL
Intervention: Web-based genetic education intervention
Number of subjects: 594

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 594
Study: 34300291

Group type: EXPERIMENTAL
Intervention: Specific rehabilitation protocol supervised by a physiotherapist
Number of subjects: 90

Group type: COMPARATOR
Intervention: General post-surgical treatment protocol
Number of subjects: 90
Study: 32564657

Group type: EXPERIMENTAL
Intervention: Lachnospiraceae enriched cluster
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Enterobacteriaceae enriched cluster
Number of subjects: 130
Study: 33482440

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (diet, exercise, and behavioral changes)
Number of subjects: 875

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 875
Study: 32111517

Group type: EXPERIMENTAL
Intervention: 30-m corridor
Number of subjects: 90

Group type: COMPARATOR
Intervention: 15-m corridor
Number of subjects: 90
Study: 36151526

Group type: EXPERIMENTAL
Intervention: Educational intervention based on Health Belief Model (HBM)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 120
Study: 34103518

Group type: COMPARATOR
Intervention: alpha1‐oleate
Number of subjects: 0
Study: 32375676

Group type: EXPERIMENTAL
Intervention: Physical Activity Counseling Intervention (PACI)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 13
Study: 35902534

Group type: EXPERIMENTAL
Intervention: EPTPassive
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: EPTActive
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control
Number of subjects: 30
Study: 36040740

Group type: EXPERIMENTAL
Intervention: Evidence-based education for nurses delivered over 18 months (8 months active education + 10 months maintenance)
Number of subjects: 8349

Group type: COMPARATOR
Intervention: Usual practice (control group)
Number of subjects: 8349

Group type: EXPERIMENTAL
Intervention: Evidence-based education for nurses
Number of subjects: 8349
Study: 33378108

Group type: EXPERIMENTAL
Intervention: Combined therapy (electroacupuncture at Hegu point (LI4) and Zusanli point (ST36) and auricular-point pressure on Shenmen point)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Single therapy (only auricular-point pressure)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Combined therapy
Number of subjects: 50
Study: 33721566

Group type: EXPERIMENTAL
Intervention: Universal HIV testing and treatment (UTT) via home-based HIV counselling and testing, linkage to care, promotion of ART adherence, and voluntary medical male circumcision.
Number of subjects: 341323
Study: 32443934

Group type: EXPERIMENTAL
Intervention: Intraperitoneal chemotherapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Dose-dense chemotherapy
Number of subjects: 50
Study: 33219678

Group type: EXPERIMENTAL
Intervention: Patients with ACHD
Number of subjects: 17189

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 17189
Study: 32066407

Group type: EXPERIMENTAL
Intervention: Self-benefit message
Number of subjects: 222

Group type: COMPARATOR
Intervention: Social-benefit message
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Self-benefit message among high-risk perceiving patients
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Self-benefit message among low-risk perceiving patients
Number of subjects: 222
Study: 33181779

Group type: EXPERIMENTAL
Intervention: Occupational medicine intervention
Number of subjects: 305

Group type: COMPARATOR
Intervention: Clinical care alone
Number of subjects: 305
Study: 33045502

Group type: EXPERIMENTAL
Intervention: Ketonuria (measured at hospital admission)
Number of subjects: 215
Study: 36385041

Group type: EXPERIMENTAL
Intervention: Compression by elastic bandage on the affected knee, once a day for 20 min, on four consecutive days
Number of subjects: 90

Group type: COMPARATOR
Intervention: Sham (elastic band placed around the affected knee without compression)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Compression by elastic bandage
Number of subjects: 90

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control
Number of subjects: 90
Study: 34373384

Group type: EXPERIMENTAL
Intervention: DKT therapy group (TJ-100 administration for 14 days postoperatively or until discharge)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care group (no administration of DKT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DKT therapy group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 0
Study: 32402650

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 0
Study: 36209035

Group type: EXPERIMENTAL
Intervention: PharmNet intervention
Number of subjects: 0
Study: 33459698

Group type: EXPERIMENTAL
Intervention: Cupping therapy with 45 mm cup
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cupping therapy with 35 mm cup
Number of subjects: 12
Study: 32317371

Group type: EXPERIMENTAL
Intervention: Surpass Evolve (Stryker)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Pipeline Flex (Medtronic)
Number of subjects: 8
Study: 36414963

Group type: EXPERIMENTAL
Intervention: Parent Management Training (PMT)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Non-Violent Resistance Training (NVR)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 270
Study: 32221707

Group type: EXPERIMENTAL
Intervention: Motor Imagery (MI) treatment during arm immobilization (5 sessions of 15 min every two hours)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Motor Imagery (MI) treatment during arm immobilization
Number of subjects: 14

Group type: COMPARATOR
Intervention: Arm immobilization without MI treatment
Number of subjects: 14
Study: 34652862

Group type: EXPERIMENTAL
Intervention: Higher carbohydrate bedtime snack
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Lower carbohydrate bedtime snack
Number of subjects: 68

Group type: COMPARATOR
Intervention: No bedtime snack
Number of subjects: 68
Study: 33254237

Group type: EXPERIMENTAL
Intervention: Sustained lung inflation (SLI) using a pressure of 20 cmH2O for 15 seconds followed by nasal continuous positive airway pressure (CPAP) of 5 cmH2O
Number of subjects: 160

Group type: COMPARATOR
Intervention: Nasal CPAP alone
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Sustained lung inflation (SLI) in sicker infants (clinical eligibility criteria)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Sustained lung inflation (SLI) in smaller babies (GA <30 weeks)
Number of subjects: 160
Study: 32310966

Group type: EXPERIMENTAL
Intervention: Community-wide mass drug administration (MDA) for STH
Number of subjects: 104

Group type: COMPARATOR
Intervention: School-based deworming
Number of subjects: 104
Study: 34227886

Group type: EXPERIMENTAL
Intervention: Drug-coated balloon angioplasty (DCBA)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Conventional percutaneous transluminal angioplasty (PTA)
Number of subjects: 138
Study: 32683735

Group type: EXPERIMENTAL
Intervention: Grid RF
Number of subjects: 8

Group type: COMPARATOR
Intervention: Laser Genesis
Number of subjects: 8
Study: 34649553

Group type: EXPERIMENTAL
Intervention: Oral health education intervention (OHE) given at baseline, third and sixth months
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group (no intervention until after the study)
Number of subjects: 240
Study: 33060089

Group type: EXPERIMENTAL
Intervention: Ibrutinib plus venetoclax (IV) for 12 cycles after a short induction with ibrutinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Continue ibrutinib after reaching undetectable minimal residual disease (uMRD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Stop ibrutinib after reaching undetectable minimal residual disease (uMRD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reinitiate IV treatment in patients who become positive for MRD again after stopping
Number of subjects: 0
Study: 35224881

Group type: EXPERIMENTAL
Intervention: Policy, systems and environmental change (PSE) strategies to promote responsive bottle-feeding
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control clinics
Number of subjects: 0
Study: 34755800

Group type: EXPERIMENTAL
Intervention: Multicomponent nursing program (spatial and temporal guidance, visual stimulus, auditive stimulus, family support)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Multicomponent nursing program
Number of subjects: 81